4basebio PLC (FRA:88Q)

Germany flag Germany · Delayed Price · Currency is EUR
8.00
-0.25 (-3.03%)
Last updated: Sep 26, 2025, 3:46 PM CET
-3.03%
Market Cap129.40M
Revenue (ttm)2.08M
Net Income (ttm)-16.81M
Shares Outn/a
EPS (ttm)-1.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume75
Average Volume283
Open8.00
Previous Close8.25
Day's Range8.00 - 8.00
52-Week Range7.50 - 16.90
Betan/a
RSI22.97
Earnings DateSep 19, 2025

About 4basebio

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5’ and 3’ ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccine... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2008
Employees 110
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 88Q
Full Company Profile

Financial Performance

In 2024, 4basebio's revenue was 933,000, an increase of 84.39% compared to the previous year's 506,000. Losses were -12.33 million, 60.9% more than in 2023.

Financial numbers in GBP Financial Statements

News

There is no news available yet.